From the KEYNOTE-001 study, the ORR was enriched 3- to 4-fold and OS was not reached after a median follow-up of 10.9 months in NSCLC patients with a PD-L1 expression proportional score of ≥50 % [74]. Here, CD274 is linked to non-small cell lung carcinoma.